S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Forecast, Price & News

$32.53
+0.16 (+0.49%)
(As of 10:30 AM ET)
Compare
Today's Range
$32.22
$32.66
50-Day Range
$32.37
$44.97
52-Week Range
$31.88
$53.50
Volume
7,293 shs
Average Volume
100,877 shs
Market Capitalization
$759.58 million
P/E Ratio
361.44
Dividend Yield
N/A
Price Target
$53.60

OrthoPediatrics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
65.7% Upside
$53.60 Price Target
Short Interest
Bearish
8.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.77mentions of OrthoPediatrics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$290,146 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.97) to ($0.88) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

282nd out of 965 stocks

Surgical & Medical Instruments Industry

39th out of 94 stocks


KIDS stock logo

About OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

KIDS Price History

KIDS Stock News Headlines

Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
4 Analysts Have This to Say About OrthoPediatrics
JMP Securities Remains a Buy on OrthoPediatrics (KIDS)
OrthoPediatrics (NASDAQ: KIDS)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
OrthoPediatrics Insider Trades Send a Signal
OrthoPediatrics (KIDS) Receives a Buy from Truist Financial
OrthoPediatrics (KIDS) Gets a Buy from JMP Securities
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Company Calendar

Last Earnings
7/31/2023
Today
9/22/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KIDS
Employees
203
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$53.60
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+65.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$1.26 million
Pretax Margin
-3.04%

Debt

Sales & Book Value

Annual Sales
$122.29 million
Book Value
$16.54 per share

Miscellaneous

Free Float
15,739,000
Market Cap
$755.84 million
Optionable
Not Optionable
Beta
0.85
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Mark C. ThrodahlMr. Mark C. Throdahl (Age 72)
    Exec. Chairman
  • Mr. David R. Bailey (Age 44)
    Pres, CEO & Director
    Comp: $588.47k
  • Mr. Fred L. HiteMr. Fred L. Hite (Age 55)
    CFO, Principal Financial & Accounting Officer, COO and Director
    Comp: $578.75k
  • Mr. Daniel J. Gerritzen (Age 53)
    Exec. VP of Legal & Gen. Counsel
    Comp: $470.44k
  • Mr. Gregory A. OdleMr. Gregory A. Odle (Age 53)
    Pres of Scoliosis
    Comp: $484.32k
  • Mr. Kevin L. Unger CHE (Age 51)
    MBA/MSHA, Pres of Enabling Technologies
    Comp: $56.25k
  • Mr. Joseph W. Hauser (Age 41)
    Pres of Trauma & Deformity Correction
    Comp: $470.44k
  • Mr. Joel Batts
    Sr. VP of Clinical & Regulatory Affairs
  • Mr. Mark Karshner
    Sr. VP of International Sales













KIDS Stock - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price forecast for 2023?

4 Wall Street analysts have issued 1-year price targets for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $60.00. On average, they anticipate the company's stock price to reach $53.60 in the next twelve months. This suggests a possible upside of 65.6% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2023?

OrthoPediatrics' stock was trading at $39.73 at the beginning of the year. Since then, KIDS stock has decreased by 18.5% and is now trading at $32.37.
View the best growth stocks for 2023 here
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) posted its earnings results on Monday, July, 31st. The company reported ($0.19) EPS for the quarter, hitting the consensus estimate of ($0.19). The business had revenue of $39.56 million for the quarter, compared to the consensus estimate of $39.11 million. OrthoPediatrics had a net margin of 0.73% and a negative trailing twelve-month return on equity of 5.03%.

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics updated its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $148.00 million-$151.00 million, compared to the consensus revenue estimate of $149.28 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is OrthoPediatrics' stock symbol?

OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."

Who are OrthoPediatrics' major shareholders?

OrthoPediatrics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (15.02%), Brown Advisory Inc. (6.88%), BlackRock Inc. (4.70%), Riverbridge Partners LLC (4.67%), Braidwell LP (3.26%) and Granahan Investment Management LLC (2.14%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends
.

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrthoPediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $32.37.

How much money does OrthoPediatrics make?

OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $755.84 million and generates $122.29 million in revenue each year. The company earns $1.26 million in net income (profit) each year or $0.09 on an earnings per share basis.

How many employees does OrthoPediatrics have?

The company employs 203 workers across the globe.

How can I contact OrthoPediatrics?

OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692.

This page (NASDAQ:KIDS) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -